pentazocine hydrochloride and naloxone hydrochloride
Generic: pentazocine hydrochloride and naloxone hydrochloride
Labeler: lupin pharmaceuticals,inc.Drug Facts
Product Profile
Brand Name
pentazocine hydrochloride and naloxone hydrochloride
Generic Name
pentazocine hydrochloride and naloxone hydrochloride
Labeler
lupin pharmaceuticals,inc.
Dosage Form
TABLET
Routes
Active Ingredients
naloxone hydrochloride .5 mg/1, pentazocine hydrochloride 50 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
43386-680
Product ID
43386-680_21e7776e-65d0-45fb-a1b2-13f49055ad64
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA075735
DEA Schedule
civ
Listing Expiration
2026-12-31
Marketing Start
2011-05-11
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
43386680
Hyphenated Format
43386-680
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
pentazocine hydrochloride and naloxone hydrochloride (source: ndc)
Generic Name
pentazocine hydrochloride and naloxone hydrochloride (source: ndc)
Application Number
ANDA075735 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .5 mg/1
- 50 mg/1
Packaging
- 100 TABLET in 1 BOTTLE (43386-680-01)
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "21e7776e-65d0-45fb-a1b2-13f49055ad64", "openfda": {"upc": ["0343386680016"], "unii": ["F850569PQR", "A36BXO4PPX"], "rxcui": ["312289"], "spl_set_id": ["017ef042-40aa-44c9-baa8-037f06356845"], "manufacturer_name": ["Lupin Pharmaceuticals,Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": true, "description": "100 TABLET in 1 BOTTLE (43386-680-01)", "package_ndc": "43386-680-01", "marketing_start_date": "20110511"}], "brand_name": "PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE", "product_id": "43386-680_21e7776e-65d0-45fb-a1b2-13f49055ad64", "dosage_form": "TABLET", "pharm_class": ["Competitive Opioid Antagonists [MoA]", "Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]", "Partial Opioid Agonist/Antagonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "43386-680", "dea_schedule": "CIV", "generic_name": "pentazocine hydrochloride and naloxone hydrochloride", "labeler_name": "Lupin Pharmaceuticals,Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": ".5 mg/1"}, {"name": "PENTAZOCINE HYDROCHLORIDE", "strength": "50 mg/1"}], "application_number": "ANDA075735", "marketing_category": "ANDA", "marketing_start_date": "20110511", "listing_expiration_date": "20261231"}